thought anatom patholog
last night close thermo fisher announc sell anatom patholog
busi billion cash phc hold corpor believ deal
make strateg sens sever front ap busi one area
thermo fisher portfolio compani lack scale compet market
roch cover emmanuel papadaki danah leica cover julian
mitchel agil dako addit busi rel laggard
specialti diagnost segment histor thermo fisher divestitur
improv underli segment growth lastli deal price repres revenu
view good return asset sale follow rumbl
around potenti sale bloomberg thermo fisher consid
sale billion patholog thermo fisher final sale price similar
report estim around time thermo fisher strong track
record portfolio manag includ disciplin divestitur addit
 prowess look across portfolio addit obviou target
think make sens prune time convers continu see
substanti opportun thermo fisher consolid asset across life scienc
tool dx industri final given recent commentari around strong
end market condit potenti share gain divestitur appear
come posit strength deal carri modest near-
term dilut expect manag re-deploy proce strateg time
action lower ep estim reflect
dilut divestitur consist management guidanc ep forecast beyond
remain unchang assum proce re-deploy time
thermo fisher expect complet divestitur model close
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
overweight thermo fisher market leader
across divers portfolio life scienc tool
diagnost impress global reach across
custom class end market compani
consist track record organ growth capit
deploy manag execut
recommend share core hold exposur
innov healthcar
see upsid thermo fisher target driven
continu biopharma strength well futur
capit deploy upsid case reflect
upsid ep
thermo fisher exposur econom activ
end market could impact growth
specif industri end market repres
around revenu downsid case
reflect downsid ep
estestestestestestestestestestincom statement growth growth growth organ adj product product product revenu inc servic servic gross margin inc sg stock comp total sg product margin oper incom margin improv w/ improv annual bs annual bs debt item expens pre-tax tax benefit net averag sharesbas ep continu opsbas adj adj full-year barclay thermo fisher scientif inc
meehan cfa herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
